S&P 500   2,789.82 (+1.45%)
DOW   23,719.37 (+1.22%)
QQQ   200.86 (+0.14%)
AAPL   267.99 (+0.72%)
FB   175.19 (+0.52%)
MSFT   165.14 (+0.01%)
GOOGL   1,206.57 (-0.04%)
AMZN   2,042.76 (-0.01%)
CGC   14.57 (-1.75%)
NVDA   262.86 (-1.53%)
BABA   196.37 (+0.20%)
MU   46.13 (-4.47%)
GE   7.14 (-2.19%)
TSLA   573.00 (+4.40%)
AMD   48.38 (-0.84%)
T   30.73 (+2.81%)
ACB   0.88 (+2.34%)
F   5.37 (+6.76%)
NFLX   370.81 (-0.08%)
BAC   24.86 (+6.01%)
GILD   73.51 (-1.97%)
DIS   104.50 (+3.39%)
PRI   102.14 (+4.75%)
S&P 500   2,789.82 (+1.45%)
DOW   23,719.37 (+1.22%)
QQQ   200.86 (+0.14%)
AAPL   267.99 (+0.72%)
FB   175.19 (+0.52%)
MSFT   165.14 (+0.01%)
GOOGL   1,206.57 (-0.04%)
AMZN   2,042.76 (-0.01%)
CGC   14.57 (-1.75%)
NVDA   262.86 (-1.53%)
BABA   196.37 (+0.20%)
MU   46.13 (-4.47%)
GE   7.14 (-2.19%)
TSLA   573.00 (+4.40%)
AMD   48.38 (-0.84%)
T   30.73 (+2.81%)
ACB   0.88 (+2.34%)
F   5.37 (+6.76%)
NFLX   370.81 (-0.08%)
BAC   24.86 (+6.01%)
GILD   73.51 (-1.97%)
DIS   104.50 (+3.39%)
PRI   102.14 (+4.75%)
S&P 500   2,789.82 (+1.45%)
DOW   23,719.37 (+1.22%)
QQQ   200.86 (+0.14%)
AAPL   267.99 (+0.72%)
FB   175.19 (+0.52%)
MSFT   165.14 (+0.01%)
GOOGL   1,206.57 (-0.04%)
AMZN   2,042.76 (-0.01%)
CGC   14.57 (-1.75%)
NVDA   262.86 (-1.53%)
BABA   196.37 (+0.20%)
MU   46.13 (-4.47%)
GE   7.14 (-2.19%)
TSLA   573.00 (+4.40%)
AMD   48.38 (-0.84%)
T   30.73 (+2.81%)
ACB   0.88 (+2.34%)
F   5.37 (+6.76%)
NFLX   370.81 (-0.08%)
BAC   24.86 (+6.01%)
GILD   73.51 (-1.97%)
DIS   104.50 (+3.39%)
PRI   102.14 (+4.75%)
S&P 500   2,789.82 (+1.45%)
DOW   23,719.37 (+1.22%)
QQQ   200.86 (+0.14%)
AAPL   267.99 (+0.72%)
FB   175.19 (+0.52%)
MSFT   165.14 (+0.01%)
GOOGL   1,206.57 (-0.04%)
AMZN   2,042.76 (-0.01%)
CGC   14.57 (-1.75%)
NVDA   262.86 (-1.53%)
BABA   196.37 (+0.20%)
MU   46.13 (-4.47%)
GE   7.14 (-2.19%)
TSLA   573.00 (+4.40%)
AMD   48.38 (-0.84%)
T   30.73 (+2.81%)
ACB   0.88 (+2.34%)
F   5.37 (+6.76%)
NFLX   370.81 (-0.08%)
BAC   24.86 (+6.01%)
GILD   73.51 (-1.97%)
DIS   104.50 (+3.39%)
PRI   102.14 (+4.75%)
Log in

NASDAQ:AMRNAmarin News Headlines

$6.05
+0.24 (+4.13 %)
(As of 04/9/2020 04:00 PM ET)
Add
Compare
Today's Range
$5.84
Now: $6.05
$6.30
50-Day Range
$4.00
MA: $12.46
$18.19
52-Week Range
$3.95
Now: $6.05
$26.12
Volume21.11 million shs
Average Volume13.38 million shs
Market Capitalization$2.16 billion
P/E RatioN/A
Dividend YieldN/A
Beta2.18

Headlines

Amarin (NASDAQ AMRN) News Headlines

Source:
DateHeadline
Amarin to announce preliminary Q1 results April 13 - Seeking AlphaAmarin to announce preliminary Q1 results April 13 - Seeking Alpha
seekingalpha.com - April 8 at 6:39 PM
Amarin to Host Conference Call on April 13, 2020 to Provide Preliminary First Quarter 2020 Results and Operational UpdateAmarin to Host Conference Call on April 13, 2020 to Provide Preliminary First Quarter 2020 Results and Operational Update
finance.yahoo.com - April 8 at 6:39 PM
Why Amarin Stock Is on the Mend Today - Motley FoolWhy Amarin Stock Is on the Mend Today - Motley Fool
www.fool.com - April 8 at 1:38 PM
Why Amarin Stock Imploded in MarchWhy Amarin Stock Imploded in March
www.msn.com - April 8 at 8:38 AM
Amarin (AMRN) Will Make Excellent Takeover Target, Says Analyst - Yahoo FinanceAmarin (AMRN) Will Make Excellent Takeover Target, Says Analyst - Yahoo Finance
finance.yahoo.com - April 6 at 3:42 PM
Amarin (AMRN) Will Make Excellent Takeover Target, Says AnalystAmarin (AMRN) Will Make Excellent Takeover Target, Says Analyst
finance.yahoo.com - April 6 at 3:42 PM
Why Is Everyone Talking About Amarin Stock? - Motley FoolWhy Is Everyone Talking About Amarin Stock? - Motley Fool
www.fool.com - April 5 at 4:30 PM
Are Amarins Blockbuster Dreams Over? - The Motley FoolAre Amarin's Blockbuster Dreams Over? - The Motley Fool
www.fool.com - April 4 at 9:04 PM
INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Amarin Corporation plc and Encourages Investors with Losses of $100,000 to Contact the Firm - Yahoo FinanceINVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Amarin Corporation plc and Encourages Investors with Losses of $100,000 to Contact the Firm - Yahoo Finance
finance.yahoo.com - April 3 at 4:19 PM
Is Amarin Stock a Buy? - Motley FoolIs Amarin Stock a Buy? - Motley Fool
www.fool.com - April 3 at 4:19 PM
Amarins Legal Struggles: An Expert Perspective - Seeking AlphaAmarin's Legal Struggles: An Expert Perspective - Seeking Alpha
seekingalpha.com - April 3 at 4:19 PM
Amarin: The Ongoing Patent Litigation And Valuation Scenarios - Seeking AlphaAmarin: The Ongoing Patent Litigation And Valuation Scenarios - Seeking Alpha
seekingalpha.com - April 3 at 4:19 PM
INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Amarin Corporation plc and Encourages Investors with Losses of $100,000 to Contact the FirmINVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Amarin Corporation plc and Encourages Investors with Losses of $100,000 to Contact the Firm
finance.yahoo.com - April 3 at 4:19 PM
Amarin Corporation (AMRN) Could Be Worth $20 if Yesterdays Appeal is Successful - Jefferies - StreetInsider.comAmarin Corporation (AMRN) Could Be Worth $20 if Yesterday's Appeal is Successful - Jefferies - StreetInsider.com
www.streetinsider.com - April 3 at 6:57 AM
SHAREHOLDER ACTION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Amarin Corporation plc and Encourages Investors with Losses In Excess of $1,000,000 to Contact the Firm - Yahoo FinanceSHAREHOLDER ACTION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Amarin Corporation plc and Encourages Investors with Losses In Excess of $1,000,000 to Contact the Firm - Yahoo Finance
finance.yahoo.com - April 3 at 1:56 AM
Is Amarin (AMRN) Stock a Solid Choice Right Now? - Yahoo FinanceIs Amarin (AMRN) Stock a Solid Choice Right Now? - Yahoo Finance
finance.yahoo.com - April 2 at 3:56 PM
Is Amarin (AMRN) Stock a Solid Choice Right Now?Is Amarin (AMRN) Stock a Solid Choice Right Now?
finance.yahoo.com - April 2 at 3:55 PM
SHAREHOLDER ACTION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Amarin Corporation plc and Encourages Investors with Losses In Excess of $1,000,000 to Contact the FirmSHAREHOLDER ACTION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Amarin Corporation plc and Encourages Investors with Losses In Excess of $1,000,000 to Contact the Firm
finance.yahoo.com - April 2 at 3:55 PM
Research Analysts Offer Predictions for Amarin Co. plcs FY2023 Earnings (NASDAQ:AMRN)Research Analysts Offer Predictions for Amarin Co. plc's FY2023 Earnings (NASDAQ:AMRN)
www.americanbankingnews.com - April 2 at 11:37 AM
Amarin Stock Tumbles After Company Loses Lawsuit Against Generic DrugmakersAmarin Stock Tumbles After Company Loses Lawsuit Against Generic Drugmakers
www.barrons.com - April 2 at 7:44 AM
Amarin: The Possible Procedural Error In The District Court JudgmentAmarin: The Possible Procedural Error In The District Court Judgment
seekingalpha.com - April 2 at 7:44 AM
Amarins (AMRN) Buy Rating Reiterated at HC WainwrightAmarin's (AMRN) Buy Rating Reiterated at HC Wainwright
www.americanbankingnews.com - April 2 at 6:49 AM
IMPORTANT INVESTOR NOTICE: The Schall Law Firm Announces it is Investigating Claims Against Amarin Corporation plc and Encourages Investors with Losses of $500,000 to Contact the Firm - Yahoo FinanceIMPORTANT INVESTOR NOTICE: The Schall Law Firm Announces it is Investigating Claims Against Amarin Corporation plc and Encourages Investors with Losses of $500,000 to Contact the Firm - Yahoo Finance
finance.yahoo.com - April 2 at 2:43 AM
Amarin jumps 18% on possible patent win - Seeking AlphaAmarin jumps 18% on possible patent win - Seeking Alpha
seekingalpha.com - April 1 at 4:43 PM
Judge’s Record Looks Unpromising for Amarin’s Appeal; Analyst Remains Bullish - Yahoo FinanceJudge’s Record Looks Unpromising for Amarin’s Appeal; Analyst Remains Bullish - Yahoo Finance
finance.yahoo.com - April 1 at 4:43 PM
Judge’s Record Looks Unpromising for Amarin’s Appeal; Analyst Remains BullishJudge’s Record Looks Unpromising for Amarin’s Appeal; Analyst Remains Bullish
finance.yahoo.com - April 1 at 4:43 PM
IMPORTANT INVESTOR NOTICE: The Schall Law Firm Announces it is Investigating Claims Against Amarin Corporation plc and Encourages Investors with Losses of $500,000 to Contact the FirmIMPORTANT INVESTOR NOTICE: The Schall Law Firm Announces it is Investigating Claims Against Amarin Corporation plc and Encourages Investors with Losses of $500,000 to Contact the Firm
finance.yahoo.com - April 1 at 4:43 PM
Citigroup Lowers Amarin (NASDAQ:AMRN) Price Target to $6.00Citigroup Lowers Amarin (NASDAQ:AMRN) Price Target to $6.00
www.americanbankingnews.com - April 1 at 8:30 AM
Amarin Highlights VASCEPA® (Icosapent Ethyl)-Related Data Presented at American College of Cardiologys Annual Scientific Session Together With World Congress of Cardiology (ACC.20/WCC) - GlobeNewswireAmarin Highlights VASCEPA® (Icosapent Ethyl)-Related Data Presented at American College of Cardiology's Annual Scientific Session Together With World Congress of Cardiology (ACC.20/WCC) - GlobeNewswire
www.globenewswire.com - April 1 at 1:43 AM
INVESTIGATION ALERT: The Schall Law Firm Announces It Is Investigating Claims Against Amarin Corporation plc and Encourages Investors with Losses of $100,000 to Contact the Firm - Yahoo FinanceINVESTIGATION ALERT: The Schall Law Firm Announces It Is Investigating Claims Against Amarin Corporation plc and Encourages Investors with Losses of $100,000 to Contact the Firm - Yahoo Finance
finance.yahoo.com - March 31 at 8:43 PM
ThermoGenesis among helathcare gainers; Amarin leads the losers - Seeking AlphaThermoGenesis among helathcare gainers; Amarin leads the losers - Seeking Alpha
seekingalpha.com - March 31 at 3:42 PM
Amarin Investors Who Lost Money Should Contact Block & Leviton: The Firm Is Investigating Securities Fraud at the Company - GlobeNewswireAmarin Investors Who Lost Money Should Contact Block & Leviton: The Firm Is Investigating Securities Fraud at the Company - GlobeNewswire
www.globenewswire.com - March 31 at 3:42 PM
Amarins Stock Plunges Following Unfavorable Patent Ruling - Yahoo FinanceAmarin's Stock Plunges Following Unfavorable Patent Ruling - Yahoo Finance
finance.yahoo.com - March 31 at 3:42 PM
Amarin's Stock Plunges Following Unfavorable Patent RulingAmarin's Stock Plunges Following Unfavorable Patent Ruling
finance.yahoo.com - March 31 at 3:42 PM
Judicial Ruling Guts Amarin (AMRN) Stock; What’s Next?Judicial Ruling Guts Amarin (AMRN) Stock; What’s Next?
finance.yahoo.com - March 31 at 3:42 PM
Amarin Target of Unusually High Options Trading (NASDAQ:AMRN)Amarin Target of Unusually High Options Trading (NASDAQ:AMRN)
www.americanbankingnews.com - March 31 at 3:27 PM
Amarin (NASDAQ:AMRN) Downgraded by Jefferies Financial Group to "Hold"Amarin (NASDAQ:AMRN) Downgraded by Jefferies Financial Group to "Hold"
www.americanbankingnews.com - March 31 at 12:49 PM
Amarin (NASDAQ:AMRN) Given New $8.00 Price Target at Stifel NicolausAmarin (NASDAQ:AMRN) Given New $8.00 Price Target at Stifel Nicolaus
www.americanbankingnews.com - March 31 at 12:48 PM
Amarin Analysts React To Vascepa Patent Loss, See Small Chance Of Overturning JudgmentAmarin Analysts React To Vascepa Patent Loss, See Small Chance Of Overturning Judgment
feeds.benzinga.com - March 31 at 11:28 AM
Amarin (NASDAQ:AMRN) Upgraded to Market Perform at OppenheimerAmarin (NASDAQ:AMRN) Upgraded to Market Perform at Oppenheimer
www.americanbankingnews.com - March 31 at 11:21 AM
Amarin (NASDAQ:AMRN) Downgraded by Goldman Sachs GroupAmarin (NASDAQ:AMRN) Downgraded by Goldman Sachs Group
www.americanbankingnews.com - March 31 at 8:08 AM
Amarin Comments on Ruling in VASCEPA® ANDA Litigation - Yahoo FinanceAmarin Comments on Ruling in VASCEPA® ANDA Litigation - Yahoo Finance
finance.yahoo.com - March 31 at 5:41 AM
Amarin Plunges After Vascepa Patents Are Invalidated - BloombergAmarin Plunges After Vascepa Patents Are Invalidated - Bloomberg
www.bloomberg.com - March 31 at 12:40 AM
Amarins Patent Defeat: Current Options - Seeking AlphaAmarin's Patent Defeat: Current Options - Seeking Alpha
seekingalpha.com - March 31 at 12:40 AM
BRIEF-Amarin Says Will Continue With Promotional Efforts For Vascepa In Treating Indicated Patients At High Risk Of Cardiovascular Events - ReutersBRIEF-Amarin Says Will Continue With Promotional Efforts For Vascepa In Treating Indicated Patients At High Risk Of Cardiovascular Events - Reuters
www.reuters.com - March 30 at 7:40 PM
Amarin Corp. (AMRN) Announces EPA Levels From VASCEPA in REDUCE-IT Strongly Correlated with Cardiovascular Outcomes - StreetInsider.comAmarin Corp. (AMRN) Announces EPA Levels From VASCEPA in REDUCE-IT Strongly Correlated with Cardiovascular Outcomes - StreetInsider.com
www.streetinsider.com - March 30 at 7:40 PM
Amarin Comments on Ruling in VASCEPA® ANDA Litigation - GlobeNewswireAmarin Comments on Ruling in VASCEPA® ANDA Litigation - GlobeNewswire
www.globenewswire.com - March 30 at 7:40 PM
Eicosapentaenoic Acid (EPA) Levels From VASCEPA® (Icosapent Ethyl) in REDUCE-IT® Strongly Correlated with Cardiovascular OutcomesEicosapentaenoic Acid (EPA) Levels From VASCEPA® (Icosapent Ethyl) in REDUCE-IT® Strongly Correlated with Cardiovascular Outcomes
finance.yahoo.com - March 30 at 7:40 PM
Amarin Stock Melts Down After Reportedly Losing Key Patent BattleAmarin Stock Melts Down After Reportedly Losing Key Patent Battle
finance.yahoo.com - March 30 at 7:40 PM
Amarin Comments on Ruling in VASCEPA® ANDA LitigationAmarin Comments on Ruling in VASCEPA® ANDA Litigation
finance.yahoo.com - March 30 at 7:40 PM
This page was last updated on 4/9/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel